Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Immunocore
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Immunocore
-
Prikvačeni tweet
On
#WorldCancerDay
, our employees share how they support the cause, using this year’s theme of #iamandiwill
@WCDLondon
pic.twitter.com/LsdwXvUFG1Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Metamorphopsia is one of the symptoms that a person with
#uvealmelanoma may present with. If you are a#eyecareprofessional, visit http://thinkuvealmelanoma.com to find out about other potential symptoms.#thinkuvealmelanomapic.twitter.com/NsWErABwl5Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
If you are a HCP interested in
#uvealmelanoma, you should check out http://thinkuvealmelanoma.com . Bertil Damato has devised a mnemonic to assist specialists to distinguish between moles and melanomas of the eye. Please contact your doctor if you are concerned about moles or melanomas.pic.twitter.com/waaMe0qkScHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
If you are a HCP and spot
#uvealmelanoma (UM), think differently. At all stages of disease, UM is intrinsically different to cutaneous melanoma. Visit http://thinkuvealmelanoma.com to learn more.#thinkuvealmelanomapic.twitter.com/4xC5W2a6QIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Although
#uvealmelanoma is an ultra-rare disease, it is the most common primary intraocular malignancy and most commonly occurs in the choroid. If you are a HCP, learn more here: http://bit.ly/2HhgXmA#thinkuvealmelanomapic.twitter.com/iXjc2Mg4naHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Next week, our team is travelling to San Francisco to attend the 38th annual
@JPMorgan Healthcare Conference. We look forward to an informative and stimulating week!#JPMHC20pic.twitter.com/WQrQyH2RZc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immunocore proslijedio/la je Tweet
A HUGE thank you to
@Immunocore for all their fundraising efforts last year
They helped raise money through different events, including:
∙ Find the Joker.
∙ Yorkshire Three Peaks
∙ Oxford Half Marathon Run.
Thank you so much for all your hard work! The OcuMel Team xpic.twitter.com/P5vissapkZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In case you missed it, we created an educational resource to help educate front-line healthcare professionals about
#uvealmelamona, a#raredisease with a poor prognosis once it spreads beyond the eye. Learn more here: http://bit.ly/2HhgXmA pic.twitter.com/tPsjrVSwuAHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
An annual eye test, including dilation of the eye, examines more than your sight. Take care of your eyes and visit an eye care professional to get your annual dilated
#eyeexampic.twitter.com/0Mv84uUvcnHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What a fantastic year 2019 has been for us. Watch below for our highlights reel
#celebratingsuccesspic.twitter.com/Re0GxMSblMHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A very
#HappyChristmas from everyone at Immunocore!pic.twitter.com/jHD0cuol4hHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As the New Year approaches, we would like to thank people around the world who have participated in clinical trials. Because of you, we are able to better understand diseases and what’s needed to treat them.pic.twitter.com/PQQTxvfHBo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
To round out our employee question week, we asked Angela about what she would say to a young woman interested in pursuing a career in science.
#WomenInSTEM#ImmunocoreChatspic.twitter.com/sfJ9nm7e4L
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Peter, Head of our Autoimmune Department, tells us why he joined Immunocore.
#ImmunocoreChatspic.twitter.com/gSLCSyk4Fd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today Ed is sharing his favourite aspect of his internship to date!
#internshipsinSTEM#ImmunocoreChatspic.twitter.com/OzkpmAglyrHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Why is cancer research so important? Shaad shares his thoughts with us.
#cancerresearch#ImmunocoreChatspic.twitter.com/JguxQ5t8qB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our team members are the backbone of what we do, and this week, we’d like you to get to know them, too. First up, we ask Sarah if she has a mentor that encouraged her to pursue a career in science.
#ImmunocoreChatspic.twitter.com/YwN2BYhlM8Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Christmas jumpers as far as the eye can see!
@savechildrenuk we are delighted to support your#ChristmasJumperDay tradition. Which is your favourite?
pic.twitter.com/3TyiO9Br9l
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’ve worked with prominent
#ophthalmology leaders to create resources for detecting#uvealmelanoma. If you are a HCP, learn more on http://ThinkUvealMelanoma.com .pic.twitter.com/p9DD8nyDFlHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today we announced the start of the first-in-human clinical trial of the third
#bispecific developed using our ImmTAC® technology platform. IMC-C103C is focused on targeting tumours that express the protein MAGE-A4. Read more here: http://bit.ly/36mFKPx#ImmunocoreNewspic.twitter.com/45CkoVB03pHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.